Assuring Vaccine Supply

How Can Vaccine Shortages Be Prevented?

Thursday, April 15, 2004

Speaker Biographies

John E. Calfee is a resident scholar at AEI. From 1980 to 1986, he served in the Bureau of Economics at the Federal Trade Commission. Mr. Calfee has taught marketing and consumer behavior in the business schools of the University of Maryland-College Park and Boston University, and he was a visiting senior fellow at the Brookings Institution. He is the author of Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Fear of Persuasion: A New Perspective on Advertising and Regulation (distributed by AEI Press, 1997).

Stephen Cochi, M.D., M.P.H., was appointed as acting director of the National Immunization Program at the Centers for Disease Control and Prevention (CDC) in January 2004. He has spent more than twenty-two years at CDC working in the field of immunization and since 1985 has served in what is now the National Immunization Program (NIP). He has had a major impact on the prevention of every vaccine-preventable disease for which NIP/CDC has lead responsibility. In the early 1990s, he supervised the creation of the national Vaccine Adverse Events Reporting System and the Vaccine Safety Datalink, the two major systems in the U.S. for reporting and monitoring adverse events following immunization. From 1993 to 2003, he led CDC’s global immunization activities and directed a $150 million annual program on priority global immunization activities with the Global Alliance for Vaccines and Immunization. Dr. Cochi has authored or coauthored more than 100 scientific journal articles, letters, and book chapters on vaccines and vaccine-preventable diseases and more than 150 CDC publications. He has served frequently as an expert consultant and lecturer on international immunization issues for the World Health Organization and other international organizations.

William Egan is currently the acting director for the Office of Vaccines Research and Review (OVRR) for FDA’s Center for Biologics Evaluation and Research (CBER). He is the permanent deputy director for OVRR, a position that he has held since 1996. The Office of Vaccines Research and Review is responsible for the licensing and subsequent regulation and control of vaccines in the United States. Mr. Egan also serves as OVRR’s associate director for research. Before joining CBER, he held post-doctoral positions in the Division of Physical Chemistry at the Lund Institute of Technology in Lund, Sweden, and at the National Institutes of Health in the National Institute for Child Health and Human Development. He has authored or coauthored more than 100 research papers and book chapters on chemistry. He has also served on many occasions as a scientific adviser on vaccine-related issues to the World Health Organization.

Philip Hosbach is vice president of New Products and Immunization Policy at Aventis Pasteur, where he oversees immunization policy development. He acts as Aventis Pasteur’s principle liaison with CDC. He has twenty years of experience in the pharmaceutical industry, including the last seventeen years focused solely on vaccines. Mr. Hosbach began his career at American Home Products in Clinical Research in 1984. He joined Aventis Pasteur (then Connaught Labs) in 1987 as clinical research coordinator and has held research and development positions of increasing responsibility, including clinical research manager and director of clinical operations. Mr. Hosbach also served as project manager for the development and licensure of Tripedia, the first diphtheria, tetanus, and acellular pertussis vaccine approved by FDA for use in infants. During his clinical research career at Aventis Pasteur, he contributed to the development and licensure of seven vaccines and has authored or coauthored several clinical research articles. From 2000 through 2002, Mr. Hosbach served on the Board of Directors for Pocono Medical Center in East Stroudsburg, Pennsylvania. Since 2003 he has actively served on the Board of Directors of Pocono Health Systems, which includes Pocono Medical Center.

Paul A. Offit, M.D., is the chief of Infectious Diseases, the director of the Vaccine Education Center, and the Henle Professor of Immunologic and Infectious Diseases at the Children’s Hospital of Philadelphia. In addition, he is a professor of pediatrics at the University of Pennsylvania School of Medicine. He is a recipient of many awards, including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, and a Research Career Development Award from the National Institutes of Health. Dr. Offit has published over 100 papers in medical and scientific journals in the areas of virology and immunology and was recently a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is also the coauthor of two books titled Vaccines: What You Should Know and Breaking the Antibiotic Habit: A Parent’s Guide to Coughs, Colds, Ear Infections, and Sore Throats.

AEI on Facebook